E-Y0001194 |
EP |
【白藜蘆醇(訂貨以英 |
Resveratrol |
|
20 mg |
1484.59 |
42 |
E-Y0001193 |
EP |
【克拉珠利(訂貨以英 |
Clazuril |
|
10 mg |
1264 |
28 |
E-Y0001192 |
EP |
【A型肝炎疫苗(滅活, |
Hepatitis A Vaccine (Inactivated, Non-Adsorbed) BRP |
|
1 mL |
1881.18 |
42 |
E-Y0001191 |
EP |
【加蘭他敏合成系統(tǒng) |
Galantamine synthetic for system suitability |
|
5 mg |
1264 |
28 |
E-Y0001190 |
EP |
【加蘭他敏自然系統(tǒng) |
Galantamine natural for system suitability |
|
10 mg |
1264 |
28 |
E-Y0001189 |
EP |
【噻托溴銨系統(tǒng)適應(yīng) |
Tiotropium for system suitability |
|
10 mg |
1264 |
28 |
E-Y0001188 |
EP |
【噻托溴銨一水合合 |
Tiotropium bromide monohydrate |
|
10 mg |
1264 |
28 |
E-Y0001187 |
EP |
【普拉克索系統(tǒng)適應(yīng) |
Pramipexole for system suitability |
|
15 mg |
1264 |
28 |
E-Y0001186 |
EP |
【沙丁胺醇雜質(zhì)J(訂 |
Salbutamol impurity J |
|
0.00045 mg |
1264 |
28 |
E-Y0001185 |
EP |
【馬兜鈴酸I(訂貨以 |
Aristolochic acid I |
|
11 mg |
1264 |
28 |
E-Y0001184 |
EP |
【三乙醇胺雜質(zhì)A(訂 |
Trolamine impurity A |
|
250 mg |
1264 |
28 |
E-Y0001183 |
EP |
【三乙醇胺雜質(zhì)B(訂 |
Trolamine impurity B |
|
1 ml |
1264 |
28 |
E-Y0001182 |
EP |
【卡托普利系統(tǒng)適應(yīng) |
Captopril for system suitability |
|
20 mg |
1264 |
28 |
E-Y0001181 |
EP |
【奧芬那君峰值鑒別 |
Orphenadrine for peak identification |
|
0.42 mg |
1264 |
28 |
E-Y0001179 |
EP |
【噻托溴銨雜質(zhì)混合 |
Tiotropium impurity mixture |
|
0.08 mg |
1264 |
28 |